Please assess the completion status of the following clinical trial:

Trial Title: Diabetes Virus Detection Project, Intervention With GAD-alum

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Newly diagnosed classical type-1 diabetes~* Positive GAD antibodies~* Fasting C-peptide \>0.1 mmol/l~* Insulin dosage \>0.1 U/kg Bodyweight/day~Exclusion Criteria:~* Pregnancy~* Weaning~* Other chronic diseases than diabetes~* Any regular medication except oral contraceptives~* Psychiatric disturbances

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- GAD-alum (Type: EXPERIMENTAL): GAD-alum administered at 0 and 1 months after inclusion
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).